Study at a glance
Can human immune cells activate vitamin D outside the kidneys?
This laboratory study asked whether human immune cells called macrophages can activate vitamin D outside the kidneys. Researchers grew the cells in several different experimental states and supplied 25-hydroxyvitamin D, a form that can be changed into active vitamin D. They measured the compounds produced and examined the enzymes involved in the conversion.
Did the researchers directly measure active vitamin D made by the cells?
Chemical testing directly detected active vitamin D produced by the cells. This showed that the cells could carry out the conversion under the conditions tested. The conclusion did not rely only on finding an enzyme that might make activation possible. The active form itself was measured.
Did all the immune-cell groups make the same amount of active vitamin D?
No. Production varied a lot between the experimental cell states. The group labelled M2a produced the most active vitamin D. The inflammatory group labelled M1 showed comparatively little processing of the supplied vitamin D. These labels describe laboratory cell categories; immune cells in living tissues can be more complex.
Does this cell study show how vitamin D supplements affect immunity in people?
The study used cells grown in the laboratory, not people taking vitamin D supplements. It did not show how much these cells contribute to active vitamin D in the blood or whether every tissue behaves in the same way. It also did not establish health benefits or show that increasing vitamin D intake would produce matching immune effects in people. The finding is that these cells can activate vitamin D locally, with the amount depending on their experimental state.
Read the full article below ↓This study investigated whether human macrophages can activate vitamin D outside the kidney and whether that ability changes according to the functional state of the cell. The researchers supplied human monocyte-derived macrophages with 25-hydroxyvitamin D [25(OH)D] and directly measured production of the active metabolite 1,25-dihydroxyvitamin D [1,25(OH)2D]. They found that human macrophages could perform this extra-renal activation and that the amount of active vitamin D produced differed substantially between macrophage phenotypes. The strongest activation occurred in M2a macrophages, while inflammatory M1 macrophages showed comparatively little metabolism of the supplied precursor.
For the complete methodological analysis and evidence boundaries, see Extra-Renal Vitamin D Activation: Full Evidence Review.
What question did this study investigate?
The researchers wanted to determine whether human macrophages can convert circulating 25(OH)D into active 1,25(OH)2D outside the kidney and whether this metabolic capacity differs according to macrophage phenotype.
The study therefore examined an important feature of extra-renal vitamin D physiology: whether peripheral immune cells possess functional vitamin D activation machinery and whether that machinery changes with cellular state.
What was studied?
Study design: Primary in-vitro experimental study using human monocyte-derived macrophages.
Experimental system: Human macrophages differentiated into different functional phenotypes, including M0, inflammatory M1, M2a and M2c macrophages.
Exposure: 25(OH)D supplied as substrate for cellular vitamin D metabolism.
Primary relevant outcome: Production of vitamin D metabolites, particularly active 1,25(OH)2D, together with assessment of vitamin D-metabolising enzyme expression.
How was the study carried out?
Human monocytes were differentiated into macrophages and experimentally polarised into different functional states. The resulting macrophage populations were supplied with 25(OH)D so that their ability to metabolise the precursor could be examined.
The researchers used liquid chromatography: tandem mass spectrometry (LC-MS/MS) to measure vitamin D metabolites produced by the cells. This included direct measurement of active 1,25(OH)2D rather than relying solely on enzyme expression as a proxy for activation.
Expression of CYP27B1, the enzyme responsible for conversion of 25(OH)D to 1,25(OH)2D, was also assessed alongside other components of cellular vitamin D metabolism.
What did the researchers find?
The researchers directly detected production of active 1,25(OH)2D by human macrophages supplied with 25(OH)D. This provided direct experimental evidence that these extra-renal human cells were capable of activating vitamin D.
The extent of this metabolism differed substantially according to macrophage phenotype. M2a macrophages showed the strongest production of active 1,25(OH)2D, whereas inflammatory M1 macrophages showed comparatively little metabolism of the supplied 25(OH)D.
The differences between macrophage states demonstrated that extra-renal vitamin D metabolism was not simply present or absent. Its magnitude depended on the functional phenotype of the cells.
What does this study support?
The study supports the proposition that vitamin D activation is not confined to the kidney. Human monocyte-derived macrophages possessed functional machinery capable of converting 25(OH)D into active 1,25(OH)2D under the experimental conditions.
It also supports a more specific conclusion: extra-renal activation capacity can vary according to cellular phenotype. Different macrophage states did not metabolise the same precursor to the same extent.
This makes the study particularly useful for understanding tissue and cellular vitamin D physiology because it demonstrates direct metabolite production rather than inferring extra-renal activation solely from the presence of CYP27B1.
What does this study not establish?
The study does not establish how much active vitamin D macrophages contribute to circulating 1,25(OH)2D concentrations in an intact person. The experiment examined local cellular metabolism under controlled in-vitro conditions rather than whole-body endocrine vitamin D production.
It also does not establish that every peripheral tissue activates vitamin D to the same extent or under the same regulatory conditions. The findings concern the particular human macrophage system examined in this experiment.
The differences between macrophage phenotypes should not be interpreted as evidence that increasing vitamin D intake will necessarily produce corresponding immune effects in humans. This was a mechanistic cell experiment, not a clinical supplementation trial.
What are the main limitations?
The principal limitation is that the study was performed in cultured human cells rather than intact human tissues or living participants. Macrophages differentiated and polarised under laboratory conditions provide a useful mechanistic system, but they do not reproduce the complete tissue environment in which macrophages normally function.
Macrophage phenotypes are also more complex in living tissues than simple experimental categories such as M1, M2a and M2c imply. The laboratory classifications are useful for investigating differences in cellular behaviour but should not be treated as complete representations of macrophage biology in vivo.
Finally, demonstrating local production of 1,25(OH)2D establishes cellular activation capacity but does not by itself establish the physiological magnitude or systemic importance of that production in humans.
Why this matters within vitamin D physiology
The kidney is the principal endocrine site associated with production of circulating active vitamin D, but vitamin D metabolism also occurs in cells outside the kidney. This study provides direct experimental evidence of that distinction by demonstrating conversion of 25(OH)D into active 1,25(OH)2D in human macrophages.
The phenotype-dependent results add another important layer. Extra-renal activation appears capable of changing with cellular state, suggesting that local vitamin D metabolism can be regulated according to the biological context of the cell rather than operating as a fixed conversion process.
The study therefore supports the concept of local extra-renal vitamin D activation while preserving an important boundary between cellular production of active vitamin D and the kidney-centred endocrine regulation of circulating 1,25(OH)2D.
For the broader physiology, see Vitamin D Activation.
For differences in vitamin D metabolism between tissues, see Tissue-Specific Vitamin D Metabolism.
For the complete analysis of this study, see Extra-Renal Vitamin D Activation: Full Evidence Review.
Primary source and publication details
Primary research paper used for this evidence summary:
View the verified primary source
Related reading
Calcitriol ameliorates renal damage in a pre-established proteinuria model
The present study investigated the benefits of calcitriol treatment in a puromycin-induced protein-uric nephropathy model.
Original paper ↗Read more →Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report
Severe hypercalcemia is often associated with uncontrolled malignancy through several mechanisms.
Original paper ↗Read more →Elevated serum 1,25(OH)2-vitamin D3 level attenuates renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction in kl/kl mice
Primary proximal tubular epithelial culture cells isolated from kl/kl mice showed no suppression in TGF-β1-induced epithelial mesenchymal transition (EMT) compared to those from HT mice.
Original paper ↗Read more →Intrinsic activation of the vitamin D antimicrobial pathway by M. leprae infection is inhibited by type I IFN
We investigated whether there is an intrinsic immune response to M.
Original paper ↗Read more →Maternal vitamin D deficiency affects the morphology and function of glycolytic muscle in adult offspring rats
Fetal stage is a critical developmental window for the skeletal muscle, but little information is available about the impact of maternal vitamin D (Vit.
Original paper ↗Read more →Older Age and High Serum Ferritin Levels Associated With the Risk of Chronic Cytopenia in Hemodialysis Patients
We aimed to investigate the incidence of chronic leukopenia or thrombocytopenia in patients with ESRD who received HD and to determine the risk factors of this complication.
Original paper ↗Read more →Podocyte mPGES‐2 Determines Renal Aging and Contributes to Senile Osteoporosis
Renal aging shortens healthspan and propagates organ dysfunction beyond the kidney, yet its molecular drivers remain incompletely defined.
Original paper ↗Read more →Prognostic impact of polypharmacy by drug essentiality in patients on hemodialysis
This study aimed to elucidate the association between the number of prescribed medicines and all-cause mortality in patients on HD, accounting for essential medicines (i.e., antihypertensives, antidiabetic medicines, and statins) and non-essential medicines.
Original paper ↗Read more →Real-World Clinical and Healthcare Resource Burden Among Burosumab-Naïve Patients With Familial Hypophosphatemia
Patient characteristics were evaluated at baseline, and disease characteristics, HCRU, and costs were evaluated over a 12-month follow-up period.
Original paper ↗Read more →Severe Refractory Calcitriol-Mediated Hypercalcemia in Diffuse Large B-Cell Lymphoma Treated With Hemodialysis
Hypercalcemia of malignancy is a recognized complication of diffuse large B-cell lymphoma (DLBCL) and is associated with decreased survival time and more advanced disease.
Original paper ↗Read more →The association between dietary acid load and odds and severity of irritable bowel syndrome in adults
In crude models, the highest compared with the lowest category of the PRAL score was significantly associated with increased odds of IBS severity in participants with BMI ≥ 25 (kg/m2) (OR = 1.54; 95% CI = (1.03 to 2.32).
Original paper ↗Read more →The effect of zoledronic acid on hip geometry in renal transplant recipients: a double-blind placebo-controlled randomized study
This study aimed to analyze the effect of zoledronic acid on the mentioned parameters in kidney transplant patients.
Original paper ↗Read more →The Effects of Omega-3 Fatty Acid on Vitamin D Activation in Hemodialysis Patients: A Pilot Study
Patients were randomized to treatment for 12 weeks with cholecalciferol supplemented with omega-3 FA or a placebo.
Original paper ↗Read more →Urine Afamin as a biomarker of lupus nephritis
This study aimed to examine the levels of Afamin in the urine and plasma of patients with systemic lupus erythematosus (SLE) and to evaluate its potential utility for diagnosing LN.
Original paper ↗Read more →Vitamin D deficiency may predict a poorer outcome of IgA nephropathy
The primary clinical endpoint was the decline of estimated glomerular filtration rate (eGFR; a 30 % or more decline compared to the baseline).
Original paper ↗Read more →The age-related changes of dietary phosphate responsiveness in plasma 1,25-dihydroxyvitamin D levels and renal Cyp27b1 and Cyp24a1 gene expression is associated with renal α-Klotho gene expression in mice
We found that 1,25-dihydroxyvitamin D levels in plasma were significantly lower in the high phosphate group than the low phosphate group for 1 and 2 month-old mice, but not 13 month-old mice.
Original paper ↗Read more →25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D: Physiological Meaning and Regulation: Full Study
Explore why 25(OH)D reflects vitamin D status while 1,25(OH)₂D is a tightly regulated active hormone, including PTH, FGF23 and renal control.
Read more →Combined Treatment with Omega-3 Fatty Acid and Cholecalciferol Increases 1,25-Dihydroxyvitamin D Levels by Modulating Dysregulation of Vitamin D Metabolism in 5/6 Nephrectomy Rats
The aim of this study was to determine whether omega-3 FA and cholecalciferol have effects on vitamin D metabolism related to CYP27B1 and 24-hydroxylase (CYP24) activities in the kidney and liver of 5/6 nephrectomy (Nx) rats.
Original paper ↗Read more →Spatial detection and consequences of nonrenal calcitriol production as assessed by targeted mass spectrometry imaging
Here, utilizing on-tissue chemical derivatization and matrix assisted laser desorption ionization-mass spectrometry imaging (MALDI-MSI), we investigated the distribution of 1,25(OH)2D3 and 25(OH)D3 in the kidney, liver, spleen, and thymus.
Original paper ↗Read more →25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D: Physiological Meaning and Regulation: Study Summary
A concise evidence summary explaining how 25(OH)D and 1,25(OH)₂D differ in physiological meaning, regulation and their roles in vitamin D testing.
Read more →Original sources
View the verified primary source
View the verified primary source.
Publication details
View the verified primary source